" class="no-js "lang="en-US"> Imran Akram Archives - Medtech Alert
Wednesday, February 08, 2023

Breaking News

Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S. Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute Roche Announces Positive Data from Global Phase III Programme for Crovalimab in PNH, a Rare Life-threatening Blood Condition Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience | MTA

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Read more

Fundraising

 Florence Raises $35 Million (£28.5m) to Revolutionise Social Care Staffing | Pharmtech Focus

Florence Raises $35 Million (£28.5m) to Revolutionise Social Care Staffing

Florence, the UK-based tech innovator for social care, announced it has raised $35 million (£28.5m) […]

  1. Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer

    Appointments

     Read more
  2. Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

    News

     Read more
  3. Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth

    Fundraising

     Read more
  4. Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer

    Appointments

     Read more
  5. TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials

    Fundraising

     Read more